首页> 外文期刊>Journal of Personalized Medicine >Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge
【24h】

Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge

机译:肌萎缩性侧索硬化症(ALS)中的个性化医学和分子相互作用网络:最新知识

获取原文
           

摘要

Multiple genes and mechanisms of pathophysiology have been implicated in amyotrophic lateral sclerosis (ALS), suggesting it is a complex systemic disease. With this in mind, applying personalized medicine (PM) approaches to tailor treatment pipelines for ALS patients may be necessary. The modelling and analysis of molecular interaction networks could represent valuable resources in defining ALS-associated pathways and discovering novel therapeutic targets. Here we review existing omics datasets and analytical approaches, in order to consider how molecular interaction networks could improve our understanding of the molecular pathophysiology of this fatal neuromuscular disorder.
机译:肌萎缩性侧索硬化症(ALS)涉及多种基因和病理生理机制,表明这是一种复杂的全身性疾病。考虑到这一点,可能有必要应用个性化医学(PM)方法为ALS患者量身定制治疗方案。分子相互作用网络的建模和分析可以代表定义ALS相关途径和发现新型治疗靶点方面的宝贵资源。在这里,我们回顾了现有的组学数据集和分析方法,以考虑分子相互作用网络如何改善我们对这种致命性神经肌肉疾病的分子病理生理学的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号